Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear
Download results

Showing 1 to 10 of 3590 Results

April 11, 2024 United States

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

$45 Million

April 11, 2024 United States

Graham Partners on its acquisition and financing of E-Technologies Group

Undisclosed

April 10, 2024 United States

Vertex Enters Into Agreement to Acquire Alpine Immune Sciences

$4.9 Billion

April 05, 2024 Belgium, France

bpostgroup to significantly strengthen its position in Europe with the acquisition of Staci

$1.4 Billion

April 01, 2024 United Kingdom, United States

Investindustrial acquires Philadelphia Macaroni Company

Undisclosed

March 28, 2024 United States

Labcorp Announces Acquisition of Select Assets of BioReference Healths Diagnostics Business

$238 Million

March 27, 2024 Ireland, Sweden

Kingspan Acquires Additional Shares In Nordic Waterproofing Holding And Thereby Crosses The Mandatory Bid Threshold

$24 Million

March 26, 2024 Germany

SEFE to become sole shareholder of German gas transport network operator WIGA through acquisition of Wintershall Deas 50.02% stake in WIGA

Undisclosed

March 26, 2024 France, United Kingdom

Juvisé Pharmaceuticals acquires multiple sclerosis drug PONVORY® (ex-US/Canada) and opens its capital to Bpifrance and Pemberton

Undisclosed

March 26, 2024 Spain, France

ORANGE and MASMOVIL sign an agreement to combine their operations in Spain

$18.9 Billion